Form 8-K - Current report:
SEC Accession No. 0000920148-25-000073
Filing Date
2025-07-10
Accepted
2025-07-10 06:58:16
Documents
14
Period of Report
2025-07-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lh-20250709.htm   iXBRL 8-K 25864
2 EX-99.1 formpr071025ex991dividenda.htm EX-99.1 5409
6 lc2020logov2.gif GRAPHIC 4887
  Complete submission text file 0000920148-25-000073.txt   155702

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lh-20250709.xsd EX-101.SCH 2025
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lh-20250709_lab.xml EX-101.LAB 22141
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lh-20250709_pre.xml EX-101.PRE 12587
16 EXTRACTED XBRL INSTANCE DOCUMENT lh-20250709_htm.xml XML 2699
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Filer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 251114801
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)